Non-Invasive Bladder Urothelial Carcinoma

What is Non-Invasive Bladder Urothelial Carcinoma?

Non-Invasive Bladder Urothelial Carcinoma is a type of bladder cancer in which the cancer cells remain confined to the inner layer, or urothelium, of the bladder wall. It is generally the most common type of bladder cancer, and is usually diagnosed at an earlier stage with a higher rate of successful treatment. Urothelial carcinoma can also spread to surrounding organs or the lymph nodes, a process known as metastasis, which causes the cancer to become more advanced but also more difficult to treat.

Signs and Symptoms

Non-Invasive Bladder Urothelial Carcinoma is most often diagnosed because of the presence of certain signs and symptoms, including:

• Blood in the urine (hematuria)
• Painful urination (dysuria)
• A frequent or urgent need to urinate (frequency or urgency)
• A feeling of incomplete emptying of the bladder

In addition, a pelvic examination or imaging tests may be used to help diagnose this type of bladder cancer.

Treatment Options

Non-Invasive Bladder Urothelial Carcinoma is typically treated with a combination of surgery, chemotherapy, radiation, and other targeted therapies. Possible treatments include:

• Surgery – removal of the tumor and surrounding lymph nodes may be necessary to treat the cancer
• Chemotherapy – medications that target cancer cells are given intravenously or orally to try to kill the cancer cells
• Radiation – high-powered energy beams are used to kill cancer cells by destroying their DNA
• Targeted therapy – drugs that specifically target cancer cells and block their growth or spread

In some cases, additional treatments may be necessary, depending on the tumor size, stage of the cancer, and other factors.

Outlook

Non-Invasive Bladder Urothelial Carcinoma is usually diagnosed at an early stage and can often be successfully treated. In some cases, the cancer may recur and require additional treatments. Regular follow-up with your doctor and regular screening tests are important to monitor the cancer and ensure early detection and successful treatment.